{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:23:36Z","timestamp":1759940616696},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.reuma.2010.10.003","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T04:57:22Z","timestamp":1298091442000},"page":"258-261","source":"Crossref","is-referenced-by-count":10,"title":["Eficacia del adalimumab en la enfermedad de Beh\u00e7et: descripci\u00f3n de 6 casos"],"prefix":"10.1016","volume":"7","author":[{"given":"Javier","family":"Calvo Catal\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Campos Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Rueda Cid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Gonz\u00e1lez-Cruz Cervellera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Baixauli Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Pastor Cubillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2010.10.003_bib0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2010.10.003_bib0010","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reuma.2010.10.003_bib0015","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.autrev.2006.01.003","article-title":"The role of biologic therapies in the management of systemic vasculitis","volume":"5","author":"Chan","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2010.10.003_bib0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","article-title":"Adalimumab for sight-threatening uveitis in Beh\u00e7et's disease","volume":"21","author":"Mushtaq","year":"2007","journal-title":"Eye"},{"key":"10.1016\/j.reuma.2010.10.003_bib0025","first-page":"438","article-title":"Treatment of Beh\u00e7et's disease with adalimumab","volume":"131","author":"Callejas-Rubio","year":"2008","journal-title":"Med Clin (Barc)"},{"issue":"4 Suppl 50","key":"10.1016\/j.reuma.2010.10.003_bib0030","first-page":"S133","article-title":"Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Beh\u00e7et's disease","volume":"26","author":"Belzunegui","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0035","doi-asserted-by":"crossref","unstructured":"Yildiz N, Alkan H, Ardic F, Topuz O. Successful treatment with adalimumab in a patient with coexisting Beh\u00e7et's disease and ankylosing spondylitis. Rheumatol Int. Published online 2010 march 30.","DOI":"10.1007\/s00296-009-1104-3"},{"key":"10.1016\/j.reuma.2010.10.003_bib0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10067-009-1272-2","article-title":"Adalimumab treatment for life threatening pulmonary artery aneurysm in Beh\u00e7et disease: a case report","volume":"29","author":"Lee","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0045","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/ibd.20869","article-title":"Intestinal Beh\u00e7et's disease: Maintenance of remission with adalimumab monotherapy","volume":"15","author":"Ariyachaipanich","year":"2009","journal-title":"Inflamm Bowel Dis"},{"issue":"Oct 9","key":"10.1016\/j.reuma.2010.10.003_bib0050","article-title":"Successful switching to adalimumab in an infliximab-allergic patient with severe Beh\u00e7et disease-related uveitis","author":"Takase","year":"2009","journal-title":"Rheumatol Int Published online"},{"issue":"2 Suppl 53","key":"10.1016\/j.reuma.2010.10.003_bib0055","first-page":"S112","article-title":"Successful treatment of recalcitrant genital ulcers of Beh\u00e7et's disease with adalimumab after failure of infliximab and etanercept","volume":"27","author":"Olivieri","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","article-title":"Adalimumab: a new modality for Beh\u00e7et's disease?","volume":"66","author":"van Laar","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2010.10.003_bib0065","unstructured":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease [no authors listed]. Lancet. 1990; 335:1078\u20131080."},{"issue":"Suppl 2","key":"10.1016\/j.reuma.2010.10.003_bib0070","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S1699-258X(06)73097-2","article-title":"III Actualizaci\u00f3n del Consenso de la Sociedad Espa\u00f1ola de Reumatolog\u00eda sobre terapia biol\u00f3gica en la artritis reumatoide","volume":"2","author":"Rodr\u00edguez-Valverde","year":"2006","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.reuma.2010.10.003_bib0075","first-page":"128","article-title":"Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et's disease; soluble TNFR-75 as a biological marker of disease activity","volume":"24","author":"Turan","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0165-5728(02)00208-4","article-title":"Vgamma9Vdelta2 T cells recovered from eyes of patients with Behcet's disease recognize non-peptide prenyl pyrophosphate antigens","volume":"130","author":"Verjans","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of behcet disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.reuma.2010.10.003_bib0090","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","article-title":"Anti-TNF therapy in the management of Beh\u00e7et's disease\u2014review and basis for recommendations","volume":"46","author":"Sfikakis","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.reuma.2010.10.003_bib0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/ard.2007.080432","article-title":"EULAR recommendations for the management of Beh\u00e7et disease","volume":"67","author":"Hatemi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2010.10.003_bib0100","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1136\/ard.2008.087957","article-title":"Management of Beh\u00e7et disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Beh\u00e7et disease","volume":"68","author":"Hatemi","year":"2009","journal-title":"Ann Rheum Dis"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X10002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X10002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T13:22:25Z","timestamp":1560000145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X10002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1699258X10002457"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2010.10.003","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}